The stability of targeted drug delivery systems, including nanoparticles, liposomes, polymeric micelles, and microsponges, is crucial for ensuring their therapeutic effectiveness and shelf life. Freeze-drying, also known as lyophilization, has become a widely used technique to enhance the stability of these formulations by removing water while preserving their structural and functional characteristics. The process consists of three key stages: freezing, primary drying (sublimation), and secondary drying (desorption), all conducted under carefully controlled conditions. The selection of cryoprotectants, such as trehalose and sucrose, and lyoprotectants, like glycine and polymers, is essential to reduce damage during the freezing and drying phases. Advanced methods, including controlled-rate freezing, annealing, and spray-freezing into liquid (SFL), further refine the process by preventing particle aggregation, maintaining particle size, and ensuring uniform ice crystal formation. Innovations in the field, such as continuous freeze-drying and microwave-assisted lyophilization, have enhanced scalability and significantly reduced drying times, making the technique more suitable for industrial production. Additionally, reconstitution testing verifies that freeze-dried formulations can be redispersed without compromising their functionality. Analytical tools such as differential scanning calorimetry (DSC), X-ray diffraction (XRD), and dynamic light scattering (DLS) are instrumental in optimizing freeze-drying parameters and assessing product stability after lyophilization. This article explores the role of freeze-drying in stabilizing targeted drug delivery systems, focusing on process optimization, excipient selection, and innovative techniques. By employing these strategies, freeze-drying ensures prolonged stability, preserves drug activity, and supports the successful development and commercialization of advanced drug delivery technologies.